Physician profile
Xiaolei Chen
NPI 1306259635
$523.74
in general payments reported to CMS, 2019-2025
13 companies · $418 in 2025
The $418 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $106 · 2025: $418.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $418.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $418.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $116.74 | 2025 | |
| Alexion Pharmaceuticals, INC. | $105.54 | 2019 | |
| Novo Nordisk INC | $101.86 | 2025 | Ozempic, Rybelsus, Wegovy |
| Glaxosmithkline, LLC. | $30.06 | 2025 | Trelegy Ellipta |
| Boston Scientific Corporation | $25.99 | 2025 | Bodyguardian |
| Radius Health, INC. | $24.32 | 2025 | Tymlos |
| Dexcom, INC. | $21.74 | 2025 | Dexcom G6 Transmitter |
| Amgen INC. | $21.20 | 2025 | Evenity |
| Xeris Pharmaceuticals, INC. | $16.36 | 2025 | Gvoke Hypopen |
| Tandem Diabetes Care, INC. | $15.57 | 2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Abbvie INC. | $15.48 | 2025 | |
| Lilly USA, LLC | $15.16 | 2025 | Zepbound |
| Exact Sciences Corporation | $13.72 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Xiaolei Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.